Switch theme
Sign up to access all valuation multiples
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
1936
3.5K+
LTM Revenue $520M
LTM EBITDA $76.1M
$662M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Core Laboratories has a last 12-month revenue (LTM) of $520M and a last 12-month EBITDA of $76.1M.
In the most recent fiscal year, Core Laboratories achieved revenue of $524M and an EBITDA of $73.5M.
Core Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Core Laboratories valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $520M | XXX | $524M | XXX | XXX | XXX |
| Gross Profit | $104M | XXX | $88.4M | XXX | XXX | XXX |
| Gross Margin | 20% | XXX | 17% | XXX | XXX | XXX |
| EBITDA | $76.1M | XXX | $73.5M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBIT | $62.0M | XXX | $49.8M | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $39.6M | XXX | $31.4M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $107M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Core Laboratories's stock price is $11.
Core Laboratories has current market cap of $504M, and EV of $662M.
See Core Laboratories trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $662M | $504M | XXX | XXX | XXX | XXX | $0.81 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Core Laboratories has market cap of $504M and EV of $662M.
Core Laboratories's trades at 1.3x EV/Revenue multiple, and 9.0x EV/EBITDA.
Equity research analysts estimate Core Laboratories's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Core Laboratories has a P/E ratio of 12.7x.
See valuation multiples for Core Laboratories and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $504M | XXX | $504M | XXX | XXX | XXX |
| EV (current) | $662M | XXX | $662M | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 8.7x | XXX | 9.0x | XXX | XXX | XXX |
| EV/EBIT | 10.7x | XXX | 13.3x | XXX | XXX | XXX |
| EV/Gross Profit | 6.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 12.7x | XXX | 16.1x | XXX | XXX | XXX |
| EV/FCF | 16.3x | XXX | 15.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCore Laboratories's last 12 month revenue growth is 0%
Core Laboratories's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $11K for the same period.
Core Laboratories's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Core Laboratories's rule of X is 15% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Core Laboratories and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 0% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | -3% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | 14% | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 15% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 7% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| SBM Offshore | XXX | XXX | XXX | XXX | XXX | XXX |
| Friedrich Vorwerk Group | XXX | XXX | XXX | XXX | XXX | XXX |
| GE Vernova T&D India | XXX | XXX | XXX | XXX | XXX | XXX |
| Suzlon Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| Inox Wind | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Core Laboratories acquired XXX companies to date.
Last acquisition by Core Laboratories was XXXXXXXX, XXXXX XXXXX XXXXXX . Core Laboratories acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Core Laboratories founded? | Core Laboratories was founded in 1936. |
| Where is Core Laboratories headquartered? | Core Laboratories is headquartered in United States of America. |
| How many employees does Core Laboratories have? | As of today, Core Laboratories has 3.5K+ employees. |
| Who is the CEO of Core Laboratories? | Core Laboratories's CEO is Mr. Lawrence Bruno. |
| Is Core Laboratories publicy listed? | Yes, Core Laboratories is a public company listed on NYS. |
| What is the stock symbol of Core Laboratories? | Core Laboratories trades under CLB ticker. |
| When did Core Laboratories go public? | Core Laboratories went public in 1995. |
| Who are competitors of Core Laboratories? | Similar companies to Core Laboratories include e.g. SBM Offshore, Friedrich Vorwerk Group, GE Vernova T&D India, Suzlon Energy. |
| What is the current market cap of Core Laboratories? | Core Laboratories's current market cap is $504M |
| What is the current revenue of Core Laboratories? | Core Laboratories's last 12 months revenue is $520M. |
| What is the current revenue growth of Core Laboratories? | Core Laboratories revenue growth (NTM/LTM) is 0%. |
| What is the current EV/Revenue multiple of Core Laboratories? | Current revenue multiple of Core Laboratories is 1.3x. |
| Is Core Laboratories profitable? | Yes, Core Laboratories is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Core Laboratories? | Core Laboratories's last 12 months EBITDA is $76.1M. |
| What is Core Laboratories's EBITDA margin? | Core Laboratories's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Core Laboratories? | Current EBITDA multiple of Core Laboratories is 8.7x. |
| What is the current FCF of Core Laboratories? | Core Laboratories's last 12 months FCF is $40.5M. |
| What is Core Laboratories's FCF margin? | Core Laboratories's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Core Laboratories? | Current FCF multiple of Core Laboratories is 16.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
